ATLASInMed Pharmaceuticals (INM) earnings date: Nov 5, 2026
InMed Pharmaceuticals (INM) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INM
| Last price | $1.63 (+1.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the InMed Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
InMed Pharmaceuticals reports on Nov 5, 2026. One email the day before, with ATLAS’s read on InMed Pharmaceuticals. You can switch it off at any time.
Alert me before INM reportsFree to start. Creating an account takes under a minute.
Notify me when InMed Pharmaceuticals reports
Track INM free Add InMed Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
INM earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Sep 28, 2026 |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -29.4% |
| Average move around a report | ±5.8% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
InMed Pharmaceuticals earnings history: last 6 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 28, 2026 | – | -$1.43 | – | – | – |
| Jul 24, 2026 | $1.55 | $1.68 | +8.4% | Beat | -11.4% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | +10.7% |
| Apr 2, 2026 | -$0.62 | -$0.71 | -14.5% | Miss | +3.7% |
| Jan 29, 2026 | $6.45 | $6.57 | +1.9% | In line | +2.8% |
| Feb 13, 2024 | -$5.50 | -$14.03 | -155.1% | Miss | +0.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INM
See the fair value, the probability range and the earnings history of InMed Pharmaceuticals on its ATLAS page.
InMed Pharmaceuticals (INM) stock analysisPlans from €3.99 a month.
InMed Pharmaceuticals earnings: frequently asked questions
When does InMed Pharmaceuticals (INM) report earnings?
InMed Pharmaceuticals is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does INM beat earnings estimates?
Of its last 5 reports with a recorded result, InMed Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -29.4%. Past results do not predict the next one.
How much does INM move around earnings?
Over its last 5 reports the stock moved an average of 5.8% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
How much does INM usually move in a day?
On a normal trading day the ATLAS model puts INM’s one-day range at about ±3.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer